Figure 3From: Presence and utility of IgA-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis: the Swedish TIRA projectIgA-class antibody status in relation to baseline number of fulfilled American College of Rheumatology criteria. Proportion of IgA-class antibodies against cyclic citrullinated peptides (IgA anti-CCP)-positive patients in relation to the number of American College of Rheumatology (ACR) criteria fulfilled at inclusion.Back to article page